Sorin Group To Support U.S. Ovatio ICD Launch With Expanded Sales Force
This article was originally published in The Gray Sheet
Executive Summary
The Sorin Group's cardiac rhythm management unit hopes to double its 100-rep U.S. sales force in 12-18 months as part of a strategy to expand its fledgling ICD market presence and support the ongoing U.S. rollout of its Ovatio implantable defibrillator